RiverPark Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
RiverPark Advisors's AGN Position: Q3 2018 in Review
RiverPark Advisors sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 6,100 shares — an estimated $1.02M sold.
RiverPark Advisors first reported a position in AGN in Q3 2016 and held it in 8 quarters. The position peaked at $1.68M in Q4 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.
- RiverPark Advisors reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
- RiverPark Advisors sold 6,100 Allergan plc shares in Q3 2018, an estimated $1.02M.
- RiverPark Advisors first reported a position in Allergan plc in Q3 2016 and held it in 8 quarters.
- RiverPark Advisors's Allergan plc position peaked at $1.68M in Q4 2016.
- 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.
Based on RiverPark Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.